[Clinical investigation of the metabolic effects of instenon and its component substances etamivan and 7-( -hydroxyethyl)-theophylline].
D001565:Benzoates / Q000008:administration & dosage*; D001786:Blood Glucose / Q000032:analysis; D050260:Carbohydrate Metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D004338:Drug Combinations; D004357:Drug Synergism; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005990:Glycerol / Q000097:blood; D006801:Humans; D007773:Lactates / Q000097:blood; D050356:Lipid Metabolism; D008297:Male; D011773:Pyruvates / Q000097:blood; D013806:Theophylline / Q000008:administration & dosage*; D014280:Triglycerides / Q000097:blood; D014665:Vasodilator Agents / Q000008:administration & dosage*
D001565:Benzoates; D001786:Blood Glucose; D004338:Drug Combinations; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D011773:Pyruvates; D014280:Triglycerides; D014665:Vasodilator Agents; D002784:Cholesterol; D013806:Theophylline; D005990:Glycerol
Klinisch-experimentelle Stoffwechseluntersuchungen mit Instenon bzw. dessen einzelsubstanzen Hexobendin, Etamivan und 7-( -Hydroxyäthyl)-theophyllin.